GB9213473D0 - Hydroxamic acid derivatives - Google Patents

Hydroxamic acid derivatives

Info

Publication number
GB9213473D0
GB9213473D0 GB929213473A GB9213473A GB9213473D0 GB 9213473 D0 GB9213473 D0 GB 9213473D0 GB 929213473 A GB929213473 A GB 929213473A GB 9213473 A GB9213473 A GB 9213473A GB 9213473 D0 GB9213473 D0 GB 9213473D0
Authority
GB
United Kingdom
Prior art keywords
acid derivatives
hydroxamic acid
hydroxamic
derivatives
acid
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
GB929213473A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
F Hoffmann La Roche AG
Original Assignee
F Hoffmann La Roche AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by F Hoffmann La Roche AG filed Critical F Hoffmann La Roche AG
Priority to GB929213473A priority Critical patent/GB9213473D0/en
Publication of GB9213473D0 publication Critical patent/GB9213473D0/en
Priority to GB939307081A priority patent/GB9307081D0/en
Priority to AU39931/93A priority patent/AU666727B2/en
Priority to TW082104397A priority patent/TW279157B/zh
Priority to CZ931183A priority patent/CZ118393A3/en
Priority to YU40293A priority patent/YU40293A/en
Priority to CA002098166A priority patent/CA2098166A1/en
Priority to SI9300313A priority patent/SI9300313A/en
Priority to EP93109443A priority patent/EP0575844B1/en
Priority to ES93109443T priority patent/ES2112929T3/en
Priority to AT93109443T priority patent/ATE162514T1/en
Priority to DK93109443T priority patent/DK0575844T3/en
Priority to DE69316456T priority patent/DE69316456T2/en
Priority to HR9213473.3A priority patent/HRP930980A2/en
Priority to IL106059A priority patent/IL106059A0/en
Priority to HU9301773A priority patent/HU9301773D0/en
Priority to NZ247926A priority patent/NZ247926A/en
Priority to ZA934398A priority patent/ZA934398B/en
Priority to MX9303672A priority patent/MX9303672A/en
Priority to SK649-93A priority patent/SK64993A3/en
Priority to BG97895A priority patent/BG97895A/en
Priority to CN93107609A priority patent/CN1054599C/en
Priority to MYPI93001217A priority patent/MY134743A/en
Priority to JP5174673A priority patent/JP2594014B2/en
Priority to BR9302642A priority patent/BR9302642A/en
Priority to UY23606A priority patent/UY23606A1/en
Priority to KR1019930011598A priority patent/KR100311556B1/en
Priority to IS4041A priority patent/IS4041A/en
Priority to PL93299465A priority patent/PL299465A1/en
Priority to FI932950A priority patent/FI932950A/en
Priority to NO932326A priority patent/NO932326L/en
Priority to GR980400819T priority patent/GR3026623T3/en
Pending legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C239/00—Compounds containing nitrogen-to-halogen bonds; Hydroxylamino compounds or ethers or esters thereof
    • C07C239/08—Hydroxylamino compounds or their ethers or esters
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/44—Iso-indoles; Hydrogenated iso-indoles
    • C07D209/48—Iso-indoles; Hydrogenated iso-indoles with oxygen atoms in positions 1 and 3, e.g. phthalimide
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C239/00—Compounds containing nitrogen-to-halogen bonds; Hydroxylamino compounds or ethers or esters thereof
    • C07C239/08—Hydroxylamino compounds or their ethers or esters
    • C07C239/22—Hydroxylamino compounds or their ethers or esters having oxygen atoms of hydroxylamino groups esterified
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C259/00—Compounds containing carboxyl groups, an oxygen atom of a carboxyl group being replaced by a nitrogen atom, this nitrogen atom being further bound to an oxygen atom and not being part of nitro or nitroso groups
    • C07C259/04—Compounds containing carboxyl groups, an oxygen atom of a carboxyl group being replaced by a nitrogen atom, this nitrogen atom being further bound to an oxygen atom and not being part of nitro or nitroso groups without replacement of the other oxygen atom of the carboxyl group, e.g. hydroxamic acids
    • C07C259/06—Compounds containing carboxyl groups, an oxygen atom of a carboxyl group being replaced by a nitrogen atom, this nitrogen atom being further bound to an oxygen atom and not being part of nitro or nitroso groups without replacement of the other oxygen atom of the carboxyl group, e.g. hydroxamic acids having carbon atoms of hydroxamic groups bound to hydrogen atoms or to acyclic carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/66—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D233/72—Two oxygen atoms, e.g. hydantoin
    • C07D233/74—Two oxygen atoms, e.g. hydantoin with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to other ring members
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/06—Dipeptides
    • C07K5/06008—Dipeptides with the first amino acid being neutral
    • C07K5/06017—Dipeptides with the first amino acid being neutral and aliphatic
    • C07K5/06026—Dipeptides with the first amino acid being neutral and aliphatic the side chain containing 0 or 1 carbon atom, i.e. Gly or Ala
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/06—Dipeptides
    • C07K5/06008—Dipeptides with the first amino acid being neutral
    • C07K5/06017—Dipeptides with the first amino acid being neutral and aliphatic
    • C07K5/06034—Dipeptides with the first amino acid being neutral and aliphatic the side chain containing 2 to 4 carbon atoms
    • C07K5/06043—Leu-amino acid
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/06—Dipeptides
    • C07K5/06008—Dipeptides with the first amino acid being neutral
    • C07K5/06078—Dipeptides with the first amino acid being neutral and aromatic or cycloaliphatic
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/06—Dipeptides
    • C07K5/06086—Dipeptides with the first amino acid being basic

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
GB929213473A 1992-06-25 1992-06-25 Hydroxamic acid derivatives Pending GB9213473D0 (en)

Priority Applications (32)

Application Number Priority Date Filing Date Title
GB929213473A GB9213473D0 (en) 1992-06-25 1992-06-25 Hydroxamic acid derivatives
GB939307081A GB9307081D0 (en) 1992-06-25 1993-04-05 Hydroxamic acid derivatives
AU39931/93A AU666727B2 (en) 1992-06-25 1993-05-31 Hydroxamic acid derivatives
TW082104397A TW279157B (en) 1992-06-25 1993-06-02
CZ931183A CZ118393A3 (en) 1992-06-25 1993-06-07 Hydroxamic acid derivatives, process of their preparation and medicaments based thereon
YU40293A YU40293A (en) 1992-06-25 1993-06-09 HYDROXAMIC ACID DERIVATIVES
SI9300313A SI9300313A (en) 1992-06-25 1993-06-10 Hydroxamic acid derivatives
CA002098166A CA2098166A1 (en) 1992-06-25 1993-06-10 Hydroxamic acid derivatives
EP93109443A EP0575844B1 (en) 1992-06-25 1993-06-14 Hydroxamic acid derivatives and pharmaceutical compositions thereof
ES93109443T ES2112929T3 (en) 1992-06-25 1993-06-14 DERIVATIVES OF HYDROXAMIC ACID AND PHARMACEUTICAL COMPOSITIONS OF THEM.
AT93109443T ATE162514T1 (en) 1992-06-25 1993-06-14 HYDROXAMIC ACID DERIVATIVES AND PHARMACEUTICAL COMPOSITIONS THEREOF
DK93109443T DK0575844T3 (en) 1992-06-25 1993-06-14 Hydroxamic acid derivatives and pharmaceutical compositions thereof
DE69316456T DE69316456T2 (en) 1992-06-25 1993-06-14 Hydroxamic acid derivatives and their pharmaceutical compositions
HR9213473.3A HRP930980A2 (en) 1992-06-25 1993-06-16 Hydroxamic acid derivatives
HU9301773A HU9301773D0 (en) 1992-06-25 1993-06-18 Hydroxamic acid derivatives
IL106059A IL106059A0 (en) 1992-06-25 1993-06-18 Hydroxamic acid derivatives,their manufacture and pharmaceutical compositions containing them
MX9303672A MX9303672A (en) 1992-06-25 1993-06-18 DERIVATIVES OF HYDROXAMIC ACID, PROCEDURE FOR ITS PREPARATION AND MEDICINES THAT CONTAIN THEM.
NZ247926A NZ247926A (en) 1992-06-25 1993-06-18 Dipeptide and dipeptide derivatives having an hydroxamic acid group, their preparation, benzoyl esters and medicaments
ZA934398A ZA934398B (en) 1992-06-25 1993-06-18 Hydroxamic acid derivatives
SK649-93A SK64993A3 (en) 1992-06-25 1993-06-22 Hydroxamic acid derivatives, method of their preparation and medicaments with their content
BG97895A BG97895A (en) 1992-06-25 1993-06-22 Derivatives of the hydroxamic acid
CN93107609A CN1054599C (en) 1992-06-25 1993-06-23 Hydroxamic acid derivatives
MYPI93001217A MY134743A (en) 1992-06-25 1993-06-23 Derivatives of hydroxyamino-succinic acid
JP5174673A JP2594014B2 (en) 1992-06-25 1993-06-23 Hydroxamic acid derivative
BR9302642A BR9302642A (en) 1992-06-25 1993-06-24 COMPOUNDS, PROCESS FOR THEIR PREPARATION, MEDICINE AND USE
NO932326A NO932326L (en) 1992-06-25 1993-06-24 hydroxamic acid derivatives
UY23606A UY23606A1 (en) 1992-06-25 1993-06-24 PROCEDURE FOR THE PREPARATION OF HYDROXAMIC ACID DERIVATIVES.-
KR1019930011598A KR100311556B1 (en) 1992-06-25 1993-06-24 Hydroxamic acid derivative
IS4041A IS4041A (en) 1992-06-25 1993-06-24 Hydroxamic acid derivatives, their method of manufacture and use as pharmaceuticals
PL93299465A PL299465A1 (en) 1992-06-25 1993-06-24 Hydroxamic acid derivatives and method of obtaining the sames
FI932950A FI932950A (en) 1992-06-25 1993-06-24 HYDROXIAMINSYRA DERIVAT
GR980400819T GR3026623T3 (en) 1992-06-25 1998-04-10 Hydroxamic acid derivatives and pharmaceutical compositions thereof.

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB929213473A GB9213473D0 (en) 1992-06-25 1992-06-25 Hydroxamic acid derivatives

Publications (1)

Publication Number Publication Date
GB9213473D0 true GB9213473D0 (en) 1992-08-12

Family

ID=10717706

Family Applications (2)

Application Number Title Priority Date Filing Date
GB929213473A Pending GB9213473D0 (en) 1992-06-25 1992-06-25 Hydroxamic acid derivatives
GB939307081A Pending GB9307081D0 (en) 1992-06-25 1993-04-05 Hydroxamic acid derivatives

Family Applications After (1)

Application Number Title Priority Date Filing Date
GB939307081A Pending GB9307081D0 (en) 1992-06-25 1993-04-05 Hydroxamic acid derivatives

Country Status (12)

Country Link
KR (1) KR100311556B1 (en)
BR (1) BR9302642A (en)
GB (2) GB9213473D0 (en)
HR (1) HRP930980A2 (en)
MX (1) MX9303672A (en)
MY (1) MY134743A (en)
PL (1) PL299465A1 (en)
SI (1) SI9300313A (en)
TW (1) TW279157B (en)
UY (1) UY23606A1 (en)
YU (1) YU40293A (en)
ZA (1) ZA934398B (en)

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8601368D0 (en) * 1986-01-21 1986-02-26 Ici America Inc Hydroxamic acids
US5189178A (en) * 1990-11-21 1993-02-23 Galardy Richard E Matrix metalloprotease inhibitors

Also Published As

Publication number Publication date
ZA934398B (en) 1993-12-27
KR940005556A (en) 1994-03-21
YU40293A (en) 1997-07-31
UY23606A1 (en) 1993-12-15
TW279157B (en) 1996-06-21
KR100311556B1 (en) 2002-02-19
MX9303672A (en) 1994-01-31
GB9307081D0 (en) 1993-05-26
SI9300313A (en) 1993-12-31
MY134743A (en) 2007-12-31
HRP930980A2 (en) 1997-02-28
PL299465A1 (en) 1994-03-07
BR9302642A (en) 1994-01-11

Similar Documents

Publication Publication Date Title
GB9307956D0 (en) Hydroxamic acid derivatives
AU2799792A (en) Hydroxamic acid derivative
HU9300166D0 (en) 4-amino-butyric acid derivatives being biaryl-substituted
EP0520277A3 (en) 7-azaisoindolinyl-quinolone- and naphthyridoncarboxylic acid derivatives
GB9027975D0 (en) Peroxycarboxylic acid
GB9411598D0 (en) Hydroxamic acid derivatives
ZA94332B (en) Quinolone- and naphtyridonecarboxylic acid derivatives
PH30227A (en) 7-Isoindolinyl-quinolone-carboxylic acid derivatives
IL103538A0 (en) Quinoxaline-carboxylic and-phosphonic acid derivatives
ZA93190B (en) Benzofuranyl- and thiophenylmethylthio-alkanecarboxylic acid derivatives
HU9403116D0 (en) Epoxy-succinic acid derivatives
HU9203124D0 (en) Imidazolyl-propenic acid derivatives
ZA9050B (en) Certain pyrrolylphenyl-substituted hydroxamic acid derivatives
GB9200420D0 (en) Amino acid derivatives
HU9400720D0 (en) Acyl-oxy-hexanic acid derivatives
ZA931367B (en) Sulphonylbenzyl-substituted imidazolylpropenoic acid derivatives
HU9302728D0 (en) Pyridazinone-acetic acid derivatives
IL110170A0 (en) 2-Oximino-2-thienyl-acetic acid derivatives
ZA93125B (en) Quinolone- and naphthyridone-carboxylic acid derivatives
ZA941923B (en) Phenoxyphenylacetic acid derivatives
HRP930980A2 (en) Hydroxamic acid derivatives
GB9305720D0 (en) Hydroxamic acid derivatives
GB9408183D0 (en) Hydroxamic acid derivatives
HU9401969D0 (en) Hydroxamic acid derivatives
ZA93737B (en) Aminobenzoic acid derivatives.